SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    US Congressional Research Service Issues Memo on Hemp Industry Issues

    By

    The US Congressional Research Service (CRS) has issued a memo on issues relating to the hemp industry ahead of the Farm Bill’s potential renewal.

    Following an agreement by The House of Republicans on a stopgap funding bill that will see a one-year extension to the 2018 Farm Bill, the CRS has issued the memo – Farm Bill Primer: Selected Hemp Industry Issues – addressing the industry.

    The success of the hemp industry is relying on the renewal of the Farm Bill, which brought a significant change for the US hemp industry by descheduling commercial hemp production and eliminating hemp from the Controlled Substances Act.

    While the 2018 farm bill only addressed issues of cultivation relating to hemp, the CRS highlights it did not address issues relating to consumer products containing hemp, with the Food and Drug Administration (FDA) preserving authority over products.

    The report states that it currently remains unclear whether changes to FDA laws and regulations fall within the jurisdiction of the agriculture committees, and that since the implementation of the 2018 bill, a number of hemp industry groups have been established that have conflicting interests.

    These differing priorities may complicate hemp policymaking, the CRS warns.

    To support hemp policymaking the report suggests a number of issues will need to be addressed and puts forward what it considers should be shared priority policies.

    One such priority includes the relaxation of the USDA’s regulatory requirements, such as reducing oversight from the DEA, removing the need for hemp testing at DEA-registered labs, and exempting hemp fibre and grain farmers from background checks, as well as sampling and testing protocols, that are required for farmers growing hemp for use in cannabinoid products.

    Product safety concerns should also be addressed, along with enhancing USDA support for hemp, such as expanding genetics research and developing processing capacity of hemp fibres for use in insulation, construction materials and plastics.

    The report also suggests that if hemp was designated as a speciality crop could qualify hemp for USDA programmes.

    10 June 2026 · Berlin Sales end May 29

    European Cannabis
    Insights Summit

    From €216

    200+ industry leaders. Exclusive German market data. A half-day briefing for B2B operators in Europe's most important emerging cannabis market.

    Stephanie Price

    Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine ‘Game Theory’ focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on “Medical Cannabis Explained”.

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free